heidib

NTLA sitting at 17.28 resistance, will it break thru or to 15s?

看多
NASDAQ:NTLA   Intellia Therapeutics, Inc.
NTLA has been flying through resistance levels from oversold conditions and looks like it's testing 17.28 resistance to establish it as support. If it closes above, likely going higher - if it rejects off of 17.28 then likely retest of high 15s before re-testing 17s. Apart from ongoing patent battles, this company was hit by a scientific paper that made unfounded claims against their gene editing tech CRSPR, which prompted a panic sell. Yet another paper discrediting the previous negative article was released today, which explains the ~6% jump. This is a super undervalued company with no debt. Either way, I sold some calls against part of my holding since they filed forms which suggest they may be planning a secondary. Waiting for a nice red day to sell more puts. Buy and hold long with co-CRSPR-patent holders EDIT & CRSP.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。